Some preclinical work explores FOXO4-p53-targeting peptides against senescent cancer cells, and the developer has discussed cancer as a research interest, but there is no human evidence that FOXO4-DRI treats cancer
It is possible that the effect of prolactin may depend on variables such as distribution of prolactin receptor isoforms and mutations, sub-cutaneous fat versus visceral fat, estrogen levels, gender, and prolactin levels, i.e
Glutathione S-transferases (rat and human)
Most HSA/FSA plans should cover this, but check with your provider to confirm
The following antibodies were used: antibodies against human eNOS, phosphor-eNOS (Ser1177), Cav-1, phosphor-Cav-1 (Tyr14), Src and phosphor-Src (Tyr416) were obtained from Cell Signaling (MA, USA)
Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer's disease